Works matching IS 14741776 AND DT 2007 AND VI 6 AND IP 3
Results: 24
A decade of fragment-based drug design: strategic advances and lessons learned.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 211, doi. 10.1038/nrd2220
- By:
- Publication type:
- Article
Multiple myeloma therapies.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 181, doi. 10.1038/nrd2269
- By:
- Publication type:
- Article
Posaconazole.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 183, doi. 10.1038/nrd2270
- By:
- Publication type:
- Article
Computational chemistry.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 251, doi. 10.1038/nrd2271
- Publication type:
- Article
A robustness-based approach to systems-oriented drug design.
- Published in:
- 2007
- By:
- Publication type:
- research
How can drug discovery for psychiatric disorders be improved?
- Published in:
- 2007
- By:
- Publication type:
- review
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 231, doi. 10.1038/nrd2197
- By:
- Publication type:
- Article
High-throughput electronic biology: mining information for drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 220, doi. 10.1038/nrd2265
- By:
- Publication type:
- Article
Psychiatric drug discovery on the couch.
- Published in:
- 2007
- Publication type:
- Editorial
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 169, doi. 10.1038/nrd2267
- Publication type:
- Article
Double death for cancer cells.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 186, doi. 10.1038/nrd2273
- By:
- Publication type:
- Article
New switch to activate class B GPCRs.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 185, doi. 10.1038/nrd2274
- By:
- Publication type:
- Article
Determining druggability.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 187, doi. 10.1038/nrd2275
- By:
- Publication type:
- Article
Collusion.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 188, doi. 10.1038/nrd2276
- By:
- Publication type:
- Article
Sleep disorders: Counting orexins.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 187, doi. 10.1038/nrd2277
- By:
- Publication type:
- Article
In brief.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 188, doi. 10.1038/nrd2278
- Publication type:
- Article
Mining the Wnt pathway for cancer therapeutics.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
Drug–target residence time and its implications for lead optimization.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
Biosimilars: the impact of their heterogeneity on regulatory approval.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 1, doi. 10.1038/nrd2093-c1
- By:
- Publication type:
- Article
Erratum: 2006 drug approvals: finding the niche.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
Big pharma slims down to bolster productivity.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 173, doi. 10.1038/nrd2284
- By:
- Publication type:
- Article
Cancer nanotechnology: small, but heading for the big time.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 174, doi. 10.1038/nrd2285
- Publication type:
- Article
Paul Herrling.
- Published in:
- 2007
- By:
- Publication type:
- Interview
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 3, p. 176, doi. 10.1038/nrd2286
- Publication type:
- Article